Disease Markers / 2020 / Article / Tab 2

Research Article

Serum Small Proline-Rich Protein 2A (SPRR2A) Is a Noninvasive Biomarker in Gastric Cancer

Table 2

Correlations of serum SPRR2A level and different clinicopathological parameters of GC.

Characteristic (%)SPRR2A level value

Sex0.192
 Male126 (63%)129.43 (78.44, 184.08)
 Female74 (37%)112.87 (67.34, 160.65)
Age (years)0.188
 <6091 (45%)102.52 (63.24, 145.34)
 ≥60109 (55%)132.74 (87.63, 206.35)
Tumor size (cm)0.236
 <5148 (74%)139.75 (88.33, 194.67)
 ≥552 (26%)111.04 (70.13, 178.35)
Histological differentiation0.670
 Moderate76 (38%)110.10 (73.95, 196.41)
 Poor124 (62%)138.37 (88.85, 182.45)
Lauren classification0.227
 Intestinal69 (35%)101.33 (60.67, 137.00)
 Diffuse73 (36%)143.48 (101.64, 184.65)
 Mixed58 (29%)113.75 (75.05, 214.55)
Lymph node metastasis0.013
 Present128 (64%)164.10 (127.54, 197.00)
 Absent72 (36%)102.00 (65.50, 184.00)
TNM stage0.005
 I+II122 (61%)113.75 (72.25, 170.04)
 III+IV78 (39%)180.70 (89.37, 283.30)

The histological examination and tumor staging process were conducted by referencing the WHO Classification of Tumours of the Digestive System. The levels of serum SPRR2A are presented as median (IQR).

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.